Benzodiazepine Use and Misuse Among Adults in the United States
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Goals were to determine the prevalence of benzodiazepine use (as prescribed and misuse), characterize misuse, and examine variation by age. METHODS: A cross-sectional analysis was conducted of 2015 and 2016 National Survey on Drug Use and Health data limited to adults ≥18 (N=86,186) and data from those respondents reporting benzodiazepine use (N=10,290). Measurements included past-year prescription benzodiazepine use and misuse ("any way a doctor did not direct"), substance use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults. RESULTS: A total of 30.6 million adults (12.6%) reported past-year benzodiazepine use-25.3 million (10.4%) as prescribed and 5.3 million (2.2%) misuse. Misuse accounted for 17.2% of overall use. Adults ages 50-64 had the highest prescribed use (12.9%). Those ages 18-25 had the highest misuse (5.2%), and those ages ≥65 had the lowest (.6%). Misuse and abuse of or dependence on prescription opioids or stimulants were strongly associated with benzodiazepine misuse. Benzodiazepine misuse without a prescription was the most common type of misuse, and a friend or relative was the most common source. Adults ages ≥50 were more likely than younger adults to use a benzodiazepine more often than prescribed and to use a benzodiazepine to help with sleep. CONCLUSIONS: Benzodiazepine use among U.S. adults was higher than previously reported, and misuse accounted for nearly 20% of use overall. Use by adults ages 50-64 now exceeds use by those ages ≥65. Patients also prescribed stimulants or opioids should be monitored for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since benzodiazepines are among the most frequently prescribed drugs in the United States, treatments for BIND represent an urgent unmet medical need [25].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundMeta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundExplicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440350031003 · Cited by 1,059 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundPark, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Help-seeking behaviour in men and women with common mental health problems: cross-sectional study
Oliver, M. I., Pearson, N., Coe, N., & Gunnell, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.4.297 · Cited by 558 · cited 1×
“This may further support the hypothesis that higher misuse is partially a function of limited access to a prescribed option—limited for younger patients due to lack of insurance and for men due to minimal disclosure of mental health concerns to providers (42).”
BackgroundBenzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
Background
Research works printed but not linked: 2
- 10.1001/archinte.1994.00420190095011 · doi:10.1001/archinte.1994.00420190095011 · Paper page
- Calcaterra SL, 2018, Clin Toxicol, 61, 1
Cited by
The epidemiology of benzodiazepine misuse: A systematic review*
Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.033 · Cited by 479
Wilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855343 · Cited by 312
“Despite the recommendation for treatment with hypnotic drugs being only 2–4 weeks, many millions of patients worldwide remain on long-term treatment (Ohayon et al., 1999; Maust et al., 2019).”
BackgroundBalancing the Risks and Benefits of Benzodiazepines
Hirschtritt, M. E., Olfson, M., & Kroenke, K. (2021) · JAMA · doi:10.1001/jama.2020.22106 · Cited by 124
Ngcobo, N. N. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01466-0 · Cited by 199
“Maust et al. observed that benzodiazepine usage increased with age among members of a large health maintenance organisation in the USA [97].”
Xu, K. Y., Hartz, S. M., Borodovsky, J. T., Bierut, L. J., & Grucza, R. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.28557 · Cited by 94
Metadata
- Authors
- Maust, D. T., Lin, L. A., & Blow, F. C.
- Affiliations
- University of Michigan (US)
- Venue
- Psychiatric Services
- Published
- 2019-02-01
- Volume
- 70
- Issue
- 2
- Pages
- 97-106
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- PMC
- PMC6358464
- OpenAlex
- W2904755589
- Cited by
- 337
- References
- 42
- Citations by year
- 2026: 40 · 2025: 50 · 2024: 72 · 2023: 48 · 2022: 56 · 2021: 27 · 2020: 35 · 2019: 8
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA045705)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine misuse, benzodiazepine use, prescription drug misuse, prevalence, age differences, substance use disorders, opioid misuse, stimulant abuse, sleep aids, benzodiazepine dependence, National Survey on Drug Use and Health
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Benzodiazepines, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Drug Prescriptions, United States, Prevalence, Young Adult, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepine Use and Misuse Among Adults in the United States. https://app.cochat.ai/papers/10.1176/appi.ps.201800321
- The paper
- Maust, D. T., Lin, L. A., & Blow, F. C. (2019). Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatric Services. https://doi.org/10.1176/appi.ps.201800321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.